Raymond James Financial Services Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-134,983	Closed	-$120K	–	3446
2022 Q4	$120K	Sell	134,983 -9,500	-7%	-$12.6K	﹤0.01%	2983
2022 Q3	$227K	Buy	144,483 +250	+0.2%	+$567	﹤0.01%	2767
2022 Q2	$290K	Sell	144,233 -16,962	-11%	-$29.3K	﹤0.01%	2619
2022 Q1	$376K	Buy	161,195 +12,264	+8%	+$38.3K	﹤0.01%	2548
2021 Q4	$693K	Sell	148,931 -66,230	-31%	-$411K	﹤0.01%	2181
2021 Q3	$1.64M	Buy	215,161 +24,907	+13%	+$211K	﹤0.01%	1615
2021 Q2	$1.84M	Buy	190,254 +10,918	+6%	+$86.9K	﹤0.01%	1519
2021 Q1	$1.48M	Buy	179,336 +34,814	+24%	+$368K	﹤0.01%	1580
2020 Q4	$986K	Sell	144,522 -93,006	-39%	-$747K	﹤0.01%	1714
2020 Q3	$2.65M	Buy	237,528 +180,005	+313%	+$1.65M	0.01%	1038
2020 Q2	$361K	Buy	57,523 +44,946	+357%	+$172K	﹤0.01%	2131
2020 Q1	$23K	Buy	12,577 +2,050	+19%	+$5.91K	﹤0.01%	2364
2019 Q4	$36K	Sell	10,527 -1,932	-16%	-$4.61K	﹤0.01%	2780
2019 Q3	$27K	Hold	12,459	–	–	﹤0.01%	2733
2019 Q2	$33K	Hold	12,459	–	–	﹤0.01%	2766
2019 Q1	$59K	Buy	+12,459	New	+$32.7K	﹤0.01%	2694